The levels of nitric oxide and asymmetric dimethylarginine in the rat endometriosis model
article
OA: closed
CC0
⤵ 15 in-corpus citations
AI-generated summary
Infliximab, etanercept, and letrozole treatments in a rat endometriosis model reduced implant size while increasing plasma ADMA and decreasing plasma nitrate/nitrite levels.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
AIM: To investigate the levels of nitric oxide (NO) and asymmetric dimethylarginine (ADMA) in all the rat endometriosis models. MATERIAL & METHODS: Forty-one rats with endometriotic implants were divided into four groups (1 to 4) and administered infliximab, etanercept, letrozole and control, respectively. There were 11 rats in group 5 (normal). The size of implants, plasma ADMA and nitrate/nitrite (NO(x) ) levels and histological score were assessed. RESULTS: In groups 1, 2 and 3, plasma ADMA levels were higher than groups 4 and 5, 296.8 ± 66.2, 285.9 ± 35.7, 200.3 ± 41.0, 125.3 ± 16.7, 111.3 ± 6.5 µmol/L, respectively, while NO(x) levels were lower than groups of control and normal 19.6 ± 3.8, 19.8 ± 4.4, 39.3 ± 6.1, 80.5 ± 5.3, and 91.1 ± 5.0 µmol/L, respectively. CONCLUSIONS: Infliximab, etanercept and letrozole have regressed endometriotic implants, decreased plasma NO(x) levels, and increased plasma ADMA levels.
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood (2-hop)
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]
References (40)
- Angiogenic Factors in Endometriosis via openalex
- Angiostatic agents prevent the development of endometriosis-like lesions in the chicken chorioallantoic membrane via openalex
- Antiangiogenic Agents Are Effective Inhibitors of Endometriosis via openalex
- Cell proliferation is increased in the endometrium of women with endometriosis via openalex
- Effects of aromatase inhibitors on proliferation and apoptosis in eutopic endometrial cell cultures from patients with endometriosis via openalex
- EPIDEMIOLOGY OF ENDOMETRIOSIS via openalex
- Expression of cyclooxygenase-2 and vascular endothelial growth factor in ovarian endometriotic cysts and their relationship with angiogenesis via openalex
- Interleukin‐1 Stimulates Macrophage Migration Inhibitory Factor Secretion in Ectopic Endometrial Cells of Women with Endometriosis via openalex
- Morphometric study of the stromal vascularization in peritoneal endometriosis via openalex
- Pathological evaluation of the rat endometriosis model via openalex
- Peritoneal endometriosis due to the menstrual dissemination of endometrial tissue into the peritoneal cavity via openalex
- Regression of endometrial explants in rats treated with the cyclooxygenase-2 inhibitor rofecoxib via openalex
- Serum and endometrial markers via openalex
- Therapeutic Effect of Angiostatin Gene Transfer in a Murine Model of Endometriosis via openalex
- W2060449870 via openalex
- W2060546762 via openalex
- W2073950591 via openalex
- W2079911821 via openalex
- W2092859490 via openalex
- W2106478344 via openalex
- W2112487069 via openalex
- W2142943611 via openalex
- W2151554519 via openalex
- W2166969544 via openalex
- W2284473629 via openalex
- W2328664855 via openalex
- W4211081176 via openalex
- W1971061508 via openalex
- W1971586374 via openalex
- W1971746374 via openalex
- W1973123086 via openalex
- W1998523124 via openalex
- W2000881220 via openalex
- W2007361075 via openalex
- W2009029293 via openalex
- W2032519662 via openalex
- W2032562223 via openalex
- W2050593194 via openalex
- W2058385357 via openalex
- W2058521337 via openalex
Cited by (14)
- Medical treatments of endometriosis: a review 2022
- What We Have Learned from Animal Models to Understand the Etiology and Pathology of Endometrioma-Related Infertility 2022
- Immunosuppression and immunotherapy in endometriosis 2021
- Endometriosis Classification and The Role of Tumor Necrosis Factor-Alpha Polymorphisms as A Therapeutic Target. 2020
- INFLUENCE OF CYTOKINES PRODUCTION, NITROGEN OXIDE METABOLITES AND LIPIDS EXCHANGE ON THE FORMATION OF EXTERNAL GENITAL ENDOMETRIOSIS STAGES IN PATIENTS OF REPRODUCTIVE AGE 2020
- A comprehensive review of hormonal and biological therapies for endometriosis: latest developments 2019
- Investigational drugs for the treatment of endometriosis, an update on recent developments 2018
- Current and emerging treatment options for endometriosis 2018
- Medical Management of Endometriosis 2017
- The effects of lauromacrogol injection into rat endometrial cysts: a preliminary experimental study 2016
- An Update on Pathophysiology and Medical Management of Endometriosis 2016
- An overview of early drug development for endometriosis 2015
- A tumor necrosis factor-α inhibitor reduces the embryotoxic effects of endometriotic peritoneal fluid 2013
- New approaches to the treatment of endometriosis 2013
Source provenance
- europepmc
- last seen: 2026-09-17T06:16:55.786923+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-05-13T22:16:48.482574+00:00
License: CC0
· commercial use OK